Nothing sinister here - more indicative of a growing and more complex company operations with expanding verticals.
Senior Management Appointments
Pro Medicus Limited (ASX: PME) is pleased to announce the following senior management
changes effective 16 March 2026.
Mr Clayton Hatch, who has held the role of Chief Financial Officer since June 2012, will assume
newly created dual roles of Head of Business Operations and Head of Investor Relations. He
will be responsible for overseeing operational initiatives within the Company, driving growth and
enhancing productivity, performance and profitability. He will also be responsible for managing
communications between the Company and its investors.
Ms Danny English will become the Chief Financial Officer succeeding Mr Hatch. Ms English
has been employed by the Company since March 2015, commencing as Group Financial
Controller before being promoted to the Head of Finance and Company Secretary three years
ago. She has extensive global financial management experience, with a deep understanding of
ASX financial reporting, governance and risk management. Danny has worked in both private
and publicly listed companies and is well versed in the complexities of dealing with both global
and local requirements, having worked in senior-level Finance roles for several years in London
and New York.
Dr Hupert, CEO congratulated Clayton Hatch on his promotion, which is recognition of his deep
knowledge of the company’s operations and investors and said: “Danny’s promotion to company
CFO reflects her extensive financial expertise that she has developed over many years.
Dr Hupert added “These management changes underscore our deliberate approach to
succession planning and highlights the depth of talent within our team. I congratulate both
Clayton and Danny on their well-deserved promotions and I look forward to working with them in
their new roles to achieve our key objective of being the leading provider of best-in-class
enterprise medical imaging solutions.”
